HOLUBIAK MYRON Z 4

4 · Citius Pharmaceuticals, Inc. · Filed Oct 12, 2023

Insider Transaction Report

Form 4

Period: 2023-10-10

Citius Pharmaceuticals, Inc.CTXR

HOLUBIAK MYRON Z

DirectorVice Chairman

Transactions

Award
Options to Purchase Common Stock
2023-10-10+400,000→ 400,000 total
Exercise: $0.70Exp: 2033-10-10→ Common Stock (400,000 underlying)

Holdings

Options to Purchase Common Stock
Exercise: $3.45Exp: 2027-09-13→ Common Stock (40,000 underlying)
40,000
Warrant to Purchase Common Stock
Exercise: $1.15Exp: 2024-08-14→ Common Stock (784,314 underlying)
784,314
Warrant to Purchase Common Stock
Exercise: $1.42Exp: 2024-04-05→ Common Stock (129,450 underlying)
129,450
Options to Purchase Common Stock
Exercise: $0.67Exp: 2029-10-08→ Common Stock (175,000 underlying)
175,000
Options to Purchase Common Stock
(indirect: See footnote)
Exercise: $2.00Exp: 2031-07-22→ Common Stock (10,000 underlying)
10,000
Options to Purchase Common Stock
Exercise: $2.04Exp: 2031-10-11→ Common Stock (650,000 underlying)
650,000
Common Stock
1,992,243
Options to Purchase Common Stock
Exercise: $8.10Exp: 2025-10-01→ Common Stock (26,667 underlying)
26,667
Options to Purchase Common Stock
Exercise: $1.62Exp: 2028-09-04→ Common Stock (150,000 underlying)
150,000
Options to Purchase Common Stock
Exercise: $2.00Exp: 2031-07-22→ Common Stock (300,000 underlying)
300,000
Warrant to Purchase Common Stock
Exercise: $0.77Exp: 2024-09-27→ Common Stock (558,597 underlying)
558,597
Options to Purchase Common Stock
Exercise: $1.01Exp: 2030-10-06→ Common Stock (200,000 underlying)
200,000
Options to Purchase Common Stock
(indirect: See footnote)
Exercise: $2.04Exp: 2031-10-11→ Common Stock (15,000 underlying)
15,000
Options to Purchase Common Stock
Exercise: $1.25Exp: 2032-10-04→ Common Stock (400,000 underlying)
400,000

Footnotes (11)

[F1]The warrant is fully vested and exercisable immediately.
[F10]The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
[F11]The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
[F2]The options vested in full On December 31, 2016.
[F3]The options vested in full on September 13, 2020.
[F4]The options vested in full on September 4, 2021.
[F5]The options vested in full on October 8, 2022.
[F6]The options vested in full on October 6, 2023.
[F7]The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
[F8]The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares.
[F9]The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.

Documents

1 file

4
ownership.xmlPrimary